title: [Off-label therapy in rheumatology].
authors.affiliation: Praxiszentrum, München, Deutschland. Klaus.Krueger@med.uni-muenchen.de
authors.forename: K
authors.initials: K
authors.lastname: Krüger
authors.forename: J
authors.initials: J
authors.lastname: Sieper
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017046:Cost Savings / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence; D016527:Drug Costs / Q000331:legislation & jurisprudence; D019317:Evidence-Based Medicine / Q000191:economics / Q000331:legislation & jurisprudence; D005858:Germany; D006801:Humans; D009313:National Health Programs / Q000191:economics* / Q000331:legislation & jurisprudence*; D056687:Off-Label Use / Q000191:economics* / Q000331:legislation & jurisprudence*; D012051:Reimbursement Mechanisms / Q000191:economics / Q000331:legislation & jurisprudence; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012219:Rheumatology / Q000191:economics* / Q000331:legislation & jurisprudence*
chemical_list: D018501:Antirheumatic Agents